US Broker Ratings

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Assessing the 15.36% Upside Potential and Strong Analyst Ratings

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a prominent player in the biotechnology sector, is attracting significant attention with its robust pipeline focused on neurodegenerative diseases and other..

Mind Medicine (MNMD) Stock Analysis: A Biotech Play with Over 100% Potential Upside

For investors with an eye on the biotechnology sector, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) presents an intriguing opportunity. As a clinical-stage biopharmaceutical company focused on..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Healthcare Staffing Challenges with a Potential 3.22% Upside

AMN Healthcare Services Inc (AMN), a prominent player in the medical care facilities sector, offers technology-enabled healthcare workforce solutions across the United States. With a market..

Relay Therapeutics, Inc. (RLAY) Investor Outlook: Analyzing the 108.91% Potential Upside in Biotech Innovation

Relay Therapeutics, Inc. (NASDAQ: RLAY) has emerged as a compelling player in the biotechnology sector, captivating investor interest with its innovative approach to drug discovery and..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring an 85.95% Potential Upside

For investors with an eye on the biotechnology sector, Arvinas, Inc. (NASDAQ: ARVN) presents an intriguing opportunity, especially given its potential upside of 85.95%. The company,..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 17% Potential Upside in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, specializes in providing home health and hospice services across the United States. With a market..

GH Research PLC (GHRS) Stock Analysis: Exploring a Promising 124.99% Upside Potential

For investors keen on the biotechnology sector, GH Research PLC (NASDAQ: GHRS) offers an intriguing opportunity with substantial upside potential. Based in Dublin, Ireland, this clinical-stage..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 130.95% Potential Upside in the Medical Devices Sector

CeriBell, Inc. (NASDAQ: CBLL), a burgeoning name in the healthcare sector, particularly in medical devices, has been capturing the attention of investors due to its promising..

Definitive Healthcare Corp. (DH) Stock Analysis: Evaluating a 54.86% Upside Potential

Definitive Healthcare Corp. (NASDAQ: DH) is a notable player in the Health Information Services industry, offering a sophisticated software as a service (SaaS) healthcare commercial intelligence..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a Potential 166.54% Upside

Investors seeking opportunities in the biotech sector may find Kura Oncology, Inc. (NASDAQ: KURA) an intriguing prospect. Headquartered in San Diego, California, this clinical-stage biopharmaceutical company..

Eton Pharmaceuticals, Inc. (ETON): Exploring a 63.58% Upside Potential and Analyst Ratings

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) stands out in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. Based in the United States,..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 47.85% Upside Potential

AxoGen, Inc. (AXGN), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its impressive potential upside of 47.85%. As..

Cronos Group Inc. (CRON) Stock Analysis: Is the Current Price a Buying Opportunity Despite a -17% Potential Downside?

Investors eyeing the cannabis industry often find themselves considering Cronos Group Inc. (NASDAQ: CRON), a key player in the cannabinoid space with a growing international footprint...

InMode Ltd. (INMD) Stock Analysis: A Closer Look at Its Growth Potential and Market Position

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, has been making waves with its innovative aesthetic medical..

Evolus, Inc. (EOLS) Stock Analysis: Unraveling a Potential 198% Upside in the Aesthetic Healthcare Market

Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, specifically within the drug manufacturers’ specialty and generic segment, is making waves in the aesthetic..

Arbutus Biopharma (ABUS) Investor Outlook: Exploring a Potential 14.63% Upside

Arbutus Biopharma Corporation (NASDAQ: ABUS) is making waves in the biotechnology sector with its promising pipeline focused on addressing infectious diseases, particularly chronic Hepatitis B virus..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Potential 234% Upside with Promising Clinical Pipeline

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, stands at the forefront of developing transformative cell and exosome-based therapeutics. With a focus on addressing unmet..

Valneva SE (VALN) Stock Analysis: Navigating a 31% Potential Upside in the Biotechnology Sector

Valneva SE (NASDAQ: VALN), a French biotechnology company, is gaining attention for its promising pipeline of vaccines targeting infectious diseases with unmet medical needs. With a..

Embecta Corp. (EMBC) Investor Outlook: Uncovering a 21.74% Potential Upside

Embecta Corp. (EMBC), a stalwart in the healthcare sector, is carving out its niche within the medical instruments and supplies industry. Headquartered in Parsippany, New Jersey,..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 115% Upside Potential in Biotech

Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing investor attention with its significant potential upside of 115.63%, as indicated by recent analyst ratings. This clinical-stage biotechnology company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds